Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Oct 5, 2021

Later deadlines: Nov 5, 2021, Feb 5, 2022, Mar 5, 2022, Jun 5, 2022, Jul 5, 2022

Grant amount: Up to US $4,000,000

Fields of work: Dementia & Alzheimer’s Disease Artificial Intelligence (AI)

Applicant type: Government Entity, Indigenous Group, Nonprofit, For-Profit Business

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE:  All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates, by 5:00 PM local time of applicant organization.

  • New: February 5, June 5, October 5
  • renewal, resubmission, revision: March 5, July 5, November 5

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review. Letters of Intent due dates are 30 days before the application due date. 

This Funding Opportunity Announcement (FOA) invites applications that propose Artificial Intelligence (AI), Machine Learning (ML), and/or Deep Learning (DL) approaches, collectively referred to here as "cognitive systems," that lead to the identification of gene mutations/variants that cause or contribute to the risk of or protection against the development of Alzheimers disease (AD) and Alzheimer's disease related dementias (ADRD) via analysis of a variety of genetic, genomic, and biomarker data that are currently available to the research community.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities

This page was last reviewed May 07, 2019 and last updated May 07, 2019